期刊文献+

血清中乙型肝炎病毒定量与免疫标志物及谷丙转氨酶之间的关系探讨 被引量:3

下载PDF
导出
摘要 目的探讨血清中乙型肝炎病毒定量(HBV DNA)与免疫标志物(HBV-M)及谷丙转氨酶(ALT)的关系.方法用Tag酶荧光定量PCR法、ELISA法、丙氨酸氨基转移酶法分别检测HBV DNA、HBV-M和ALT.结果 HBsAg阳性者,HBV DNA阳性率61.9%;HBsAg阴性者中HBV DNA阳性率1.7%;HBsAg、HBeAg、和/或抗HBc阳性者,HBV DNA阳性率99%,其中载量>106为91%;HBsAg、抗HBe、抗HBc阳性者,HBV DNA阳性率38.3%,其中>106为9%;其它HBV-M模式下,HBV DNA阳性率1.3%~18.3%;HBV-M全阴模式下,HBV DNA 阳性率1.3%;HBV DNA阳性者ALT升高,与阴性组间有非常显著差异(P<0.01),HBV阳性而病毒载量不同的两组间,ALT值无显著差异(P>0.05).结论 HBsAg阴性者,HBV DNA也可阳性.HBeAg的阴转不能说明是病毒复制的静息与好转,有些HBeAg/抗HBe的转换后,HBV DNA>106.ALT的升高常伴有HBV DNA阳性,HBV DNA阳性者不一定ALT升高,且ALT的升高程度不与HBV DNA值正相关.
出处 《中国血液流变学杂志》 CAS 2005年第3期470-471,共2页 Chinese Journal of Hemorheology
  • 相关文献

参考文献5

二级参考文献34

  • 1骆抗先.HBsAg阴性的HBV感染[A]..骆抗先乙型肝炎基础与临床[C].北京,人民卫生出版社,1997.246-259.
  • 2Kodell R G, Ishak K G, Black W C, et al. Formulation and application of a numerical scoring system for assessing histological activity in a symptomatic chronic active hepatitis [ J ]. Hepatology, 1981,1 ( 38 ):431-435.
  • 3Sheen I S,Liaw Y F, Lin D Y, et al. Role of hepatitis C and delta virus in the termination of chronic hepatitis B surface antigen carrier state:a multivariate analysis in a logitudinal follow-up study [ J ]. J Infect Dis, 1994,170(16) :358-360.
  • 4骆抗先,主编.乙型肝炎基础和临床.第2版.北京:人民卫生出版社,2001.49-50.
  • 5Dieye A, Obami-Ttou V, Barry MF, et al. Association between Class IHLA allles and HBs antigen carrier status among blood donors in Senegal. Dakar Med, 1999,44(2) : 166-170.
  • 6Barth H, Klein R, Berg PA, et al. Tnduction of T helper cell type 1 response and elimination of HBeAg during treatment with TL-12 in a patient with therapy-refractory chronic hepatitis B. HepatogastroenteroLogY, 2001,48 (38) : 553-555.
  • 7Merkle H, Deutschle T, Gastrock-Balitsch T, et al. H-2(d) mice born to and reared by HBeAg-transgenic mothers do not develop T cell tolerance toward the hepatitis B virus core gene products. Virology, 2000, 273 ( 1 ) :149-159.
  • 8Khakoo SI, Ling R, Scott l, et al. Cytotoxic T lymphocyte resDonses and CTL epitope escape mutation in HBsAg, anti-HBe positi. ve individuals.Gut, 2000,47(1) : 137-143.
  • 9Zavaglia C, Severini R, Tinelli C, et al. A randomized, controlled study of thymosin-alphal therapy in patients with anti-HBe, HBV-DNA-positive chronic hepatitis B. Dig Dis Sci, 2000, 45(4) :690-696.
  • 10Krastev Z, Jelev D, Antonov K, et al. Chronic HBV infection. Tmmunomodulation with levamisole in viremic HBeAg positive or anti-HBe positive patients-a pilot study. Hepatogastroenterology, 1999, 46(30) : 3184-3188.

共引文献14040

同被引文献26

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部